Characterizing visual function in Macular Telangiectasia Type 2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016010

Enrollment

Registered

2018-12-20

Start date

2019-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Telangiectasia Type 2 H35.3

Interventions

Group 1: Visual function of patients with Macular Telangiectasia Type 2 will be assessed using diverse visual functions tests Group 2: Visual function of control patients will be assessed using dive

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with Macular Telangiectasia Type 2 or healthy subjects

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
-Contrast sensitivity -low contrast visual acuity -time course of contrastsensitivity following bleaching	—

Secondary

Measure	Time frame
-visual acuity -reading speed -microperimetry - OCT-Angiography	—

Countries

Germany

Contacts

Public ContactFelicitas Bucher

Klinik für Augenheilkunde FreiburgUniversitätsklinikum Freiburg

felicitas.bucher@uniklinik-freiburg.de076127040010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026